Novo Nordisk's pricing approaches in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of price gouging, declaring the stark contrast involving U.S. selling prices and people in Europe and copyright.Novo Nordisk is linked to govt funded collaborative study initiatives with other industrial and gove